Bioasis Technologies Inc.
BIOAF · OTC
2/28/2022 | 2/28/2021 | 2/28/2020 | 2/28/2019 | |
|---|---|---|---|---|
| Revenue | $38 | $4,078 | $606 | $1,422 |
| % Growth | -99.1% | 572.5% | -57.4% | – |
| Cost of Goods Sold | $1,226 | $1,238 | $0 | $10 |
| Gross Profit | -$1,188 | $2,840 | $606 | $1,412 |
| % Margin | -3,150.2% | 69.6% | 100% | 99.3% |
| R&D Expenses | $1,226 | $1,238 | $2,034 | $1,954 |
| G&A Expenses | $2,408 | $2,460 | $3,174 | $4,314 |
| SG&A Expenses | $2,408 | $2,460 | $3,174 | $4,314 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,635 | $3,698 | $5,208 | $6,269 |
| Operating Income | -$4,823 | -$858 | -$5,194 | -$6,239 |
| % Margin | -12,784.5% | -21% | -856.5% | -438.7% |
| Other Income/Exp. Net | $1,863 | $1,556 | $545 | $1,384 |
| Pre-Tax Income | -$2,960 | $698 | -$4,056 | -$3,473 |
| Tax Expense | $0 | $0 | $0 | -$1,384 |
| Net Income | -$2,960 | $698 | -$4,056 | -$3,473 |
| % Margin | -7,846.5% | 17.1% | -669% | -244.3% |
| EPS | -0.041 | 0.01 | -0.065 | -0.061 |
| % Growth | -498.1% | 115.8% | -6.2% | – |
| EPS Diluted | -0.041 | 0.01 | -0.065 | -0.061 |
| Weighted Avg Shares Out | 72,167 | 68,115 | 62,271 | 56,675 |
| Weighted Avg Shares Out Dil | 72,167 | 68,115 | 62,271 | 56,675 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $654 | $0 | $47 | $0 |
| Depreciation & Amortization | $55 | $58 | $71 | $72 |
| EBITDA | -$3,542 | $438 | -$4,536 | -$4,790 |
| % Margin | -9,388.6% | 10.7% | -748% | -336.8% |